Accelerate Diagnostics: A Stock Story of Earnings Woes in Q4 2023 Accelerate Diagnostics: A Stock Story of Earnings Woes in Q4 2023

Published On: March 28, 2024 10:49 pm

AXDX stock - AXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023

Accelerate Diagnostics (NASDAQ:AXDX) recently unveiled the fiscal performance for the fourth quarter of 2023.

The earnings per share stood at -89 cents, a significant miss from the anticipated -62 cents.
On the revenue front, the company brought in $3.03 million, falling short of the projected $3.45 million by 12.26%.

InvestorPlace Earnings, powered by TradeSmith data, ensures swift coverage of quarterly reports. It summarizes key metrics like EPS and revenue, alongside comparisons to analyst forecasts. These reports are generated without human input to deliver the latest facts promptly. For any issues or corrections, reach out to [email protected].

Article printed from InvestorPlace Media, Click here for detailed information.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.